Skip to content
healthcare.dev

Adalimumab

NDC 61314-325, adalimumab-adaz, injection, solution, from Sandoz Inc.

Product NDC
61314-325
Status
Listed
Labeler
Sandoz Inc
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761071
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61314-325 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ADALIMUMAB80 mg/.8mL

Pharmacologic classes

Antibodies, Monoclonal [CS]; Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]

Package NDCNDC-11Package
61314-325-20613140325202 SYRINGE in 1 CARTON (61314-325-20) / .8 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3468792f-63ef-4916-8ed1-8214f327d9dd

Use it

Look up 61314-325 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61314-325 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61314-325. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.